Log in here
Top Journalists
>
Vandana Singh

Vandana Singh

Staff Writer at Benzinga

Contact this person
Email address
v*****@*******.comGet email address
Influence score
59
Phone
(XXX) XXX-XXXXGet mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

benzinga.com

Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks

Artisan Partners calls on Novartis to revamp board governance and acquisition oversight following sharp stock declines after trial setbacks.
about 1 month ago
benzinga.com

Eli Lilly Utilizes Weight-Loss Drug Profits To Fund Women's Health ...

Eli Lilly is expanding into women's health, targeting endometriosis and pregnancy disorders by hiring experts and strategic investments.
about 1 month ago
benzinga.com

Evommune Halts Atopic Dermatitis Program Following Trial Failure

Evommune halts EVO756 development in atopic dermatitis following a Phase 2b trial failure, shifting focus to its EVO301 candidate.
about 1 month ago
benzinga.com

Structure Therapeutics Advances Weight-Loss Pills With New Clinical...

Structure Therapeutics Advances Weight-Loss Pills With New Clinical Data
about 1 month ago
benzinga.com

DaVita Reaches Preliminary Settlement Class Agreement Following Ran...

A federal court preliminarily approves a class action settlement for 2.3 million patients affected by the DaVita ransomware attack.
about 1 month ago
benzinga.com

Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Me...

FDA warns of risks from unapproved compounded GLP-1 drugs including semaglutide and tirzepatide amid rising adverse event reports.
about 1 month ago
benzinga.com

Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?

MIRA Pharmaceuticals (NASDAQ: MIRA) stock jumps as MIRA-55 meets key preclinical study milestones for non-opioid inflammatory pain relief.
about 1 month ago
benzinga.com

What's Going On With Cytokinetics Stock Today? - Cytokinetics (NASD...

What's Going On With Cytokinetics Stock Today? - Cytokinetics (NASDAQ:CYTK)
about 2 months ago
benzinga.com

McKesson Buys Precision Medicine to Expand Clinical Research and Co...

McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
about 2 months ago
benzinga.com

What's Going On With Jazz Pharmaceuticals Stock Tuesday? - Jazz Pha...

FDA approves Jazz Pharmaceuticals' Ziihera combinations for first-line treatment of HER2-positive gastroesophageal adenocarcinoma.
about 2 months ago
benzinga.com

Why Is Werewolf Therapeutics Stock Gaining Friday? - Werewolf Thera...

Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
about 2 months ago